Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Zilico Ltd
| Project | New approach for immediate pain free diagnosis of oral cancers |
|---|---|
| Description |
Electrical Impedance Spectroscopy (EIS) uses alternating current at varying frequency to measure the impedance of tissue in-vivo. The magnitude of impedance and the dependence on frequency are both functions of the tissue composition. Measuring the impedance of cells across a range of frequencies will generate a spectrum that is characteristic of the biological tissue. Changes in the impedance spectrum can therefore be directly related to changes in the underlying nature of the tissue. Visual indicators of disease can be misleading or non-apparent and so a non-visual method is needed. Using EIS it is possible to differentiate tissue types and detect dysplasia in real time, even when the cell changes cannot be detected optically. |
| Funding | £ 884,243 |
| Competition | Competition 15 - Dentistry, Oral Health & Oral Cancers |
| Competition Date | May 2019 |
| Health Innovation Network Partner | Greater Manchester AHSN |
| Website | https://www.zilico.co.uk |
Amaphase Ltd
| Project | |
|---|---|
| Description |
Amaphase is a form of transdermal delivery technology specifically for the self-care of chronic musculoskeletal conditions, such as osteoarthritis. |
| Funding | £ 83,083 |
| Competition | Competition 15 - Improving Outcomes in Musculoskeletal Disorders |
| Competition Date | May 2019 |
| Categories | Musculoskeletal |
Amodisc Ltd.
| Project | Amaphase |
|---|---|
| Description |
Amaphase is a form of transdermal delivery technology specifically for the self-care of chronic musculoskeletal conditions, such as osteoarthritis. |
| Funding | £ 79,917 |
| Competition | Competition 15 - Improving Outcomes in Musculoskeletal Disorders |
| Competition Date | May 2019 |
| Categories | Musculoskeletal |